Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
- PMID: 38465342
- PMCID: PMC10921473
- DOI: 10.1515/biol-2022-0814
Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
Abstract
Interstitial pneumonia with autoimmune features (IPAF) is a type of interstitial lung disease (ILD) with immune features that do not meet the diagnostic criteria for specific connective tissue diseases (CTDs). This retrospective case-control study investigated the role of serum B-cell-activating factor of the tumor necrosis factor family (BAFF) and interleukin (IL)-17 as biomarkers for IPAF. The differences in serum BAFF, IL-17, and IL-10 were compared among patients with idiopathic pulmonary fibrosis (IPF), IPAF, ILD associated with CTD (CTD-ILD), and healthy controls. The patients were treatment naïve. The correlations of BAFF with IL-10, IL-17, and pulmonary function were analyzed. The classifiable value of BAFF for IPAF was examined. The results showed that the serum levels of BAFF and IL-17 in the IPAF and CTD-ILD groups were higher than in the IPF group. High BAFF levels and high predicted diffusion capacity of the lungs for carbon monoxide (DLCO) were independent predictive factors for IPAF vs IPF. In the IPAF and CTD-ILD groups, serum BAFF levels were negatively correlated with predicted values of forced vital capacity (FVC%) and diffusing capacity of the lungs for carbon monoxide (DLCO%) and positively correlated with serum IL-17 and IL-10 levels. The cutoff value of combined BAFF and IL-17 was 0.704, and the sensitivity and specificity for classifying IPAF were 78.9 and 95.7%, respectively. In conclusion, combining serum BAFF and IL-17 as a biomarker may have classifiable value in differentiating IPAF from other forms of ILD.
Keywords: BAFF; inflammatory mechanism; interleukin-17; interstitial lung disease; pneumonia autoimmune features.
© 2024 the author(s), published by De Gruyter.
Conflict of interest statement
Conflict of interest: Authors state no conflict of interest.
Figures
Similar articles
-
Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.Chest. 2017 Jul;152(1):103-112. doi: 10.1016/j.chest.2017.03.004. Epub 2017 Mar 12. Chest. 2017. PMID: 28300570 Free PMC article.
-
Characteristics and risk factors of interstitial pneumonia with autoimmune features.Respir Med. 2024 Jan;221:107500. doi: 10.1016/j.rmed.2023.107500. Epub 2023 Dec 22. Respir Med. 2024. PMID: 38142756
-
Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.Respiration. 2019;98(6):534-545. doi: 10.1159/000503689. Epub 2019 Oct 30. Respiration. 2019. PMID: 31665737
-
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.Autoimmun Rev. 2016 Jan;15(1):61-70. doi: 10.1016/j.autrev.2015.09.003. Epub 2015 Sep 16. Autoimmun Rev. 2016. PMID: 26384526 Review.
-
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).J Clin Med. 2017 May 4;6(5):51. doi: 10.3390/jcm6050051. J Clin Med. 2017. PMID: 28471413 Free PMC article. Review.
Cited by
-
The relationship of peripheral blood lncRNA-PVT1 and miR-146a levels with Th17/Treg cytokines in patients with Hashimoto's thyroiditis and their clinical significance.Biomol Biomed. 2024 Sep 6;24(5):1170-1177. doi: 10.17305/bb.2024.10237. Biomol Biomed. 2024. PMID: 38761409 Free PMC article.
References
-
- Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, et al. An official European Respiratory Society/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976–87. - PubMed
-
- Navaratnam V, Ali N, Smith CJ, McKeever T, Fogarty A, Hubbard RB. Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis? Respir Med. 2011;105(12):1925–30. - PubMed
-
- Nayfeh AS, Chippa V, Moore DR Nonspecific interstitial pneumonitis. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Venu Chippa declares no relevant financial relationships with ineligible companies. Disclosure: Douglas Moore declares no relevant financial relationships with ineligible companies; 2023.
-
- Kameda M, Otsuka M, Chiba H, Kuronuma K, Hasegawa T, Takahashi H, et al. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features. PLoS one. 2020;15(11):e0241719. - PMC - PubMed
LinkOut - more resources
Full Text Sources